# DEFINITY RT

NDC: 11994-017
Generic name: perflutren
Labeler / Manufacturer: Lantheus Medical Imaging, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SUSPENSION
Routes: INTRAVENOUS
Marketing started: 20201001

FDA application: NDA021064

## Active ingredients

- PERFLUTREN: 6.52 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"11994-017"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=11994-017
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7b9de6ab-a3ac-40c9-8103-139dc7a464a2